AMD-Xilinx Is Taking Chip Deal Fever Too Far, , on October 9, 2020 at 5:49 pm

Financial News
By
On October 9, 2020
In Financial News
Tags:

(Bloomberg Opinion) — It looks as if 2020’s chip merger mania isn’t going to stop anytime soon. We’ve already seen the $21 billion tie-up between Analog Devices Inc. and Maxim Integrated Products Inc., followed by Nvidia Corp.’s $40 billion planned takeover of Arm Ltd. Now comes word that Advanced Micro Devices Inc. is in advanced talks to buy Xilinx Inc. in a transaction that could value the target at $30 billion. The first two deals make decent sense; I am not so sure about this latest one.The semiconductor industry is undergoing a wave of consolidation as companies look to achieve greater market heft and offer customers a broader range of integrated products. The merger of Analog and Maxim unites the No. 2 and No. 3 players in the analog chip market, creating a more formidable competitor while offering opportunities for the combined company to cut costs. Nvidia —  which is big in the market for graphics chips used in cloud computing, artificial intelligence and video games — sought Arm for its know-how in general-purpose processors, a core component it needs to offer integrated computing systems. An AMD-Xilinx transaction lacks these sort of obvious synergies or strategic rationales.First, the two companies couldn’t be more different. AMD is a leading maker of central-processing units (CPUs) and graphics processors, which are used for some of the hottest growth markets and aimed at both consumers and companies. In contrast, Xilinx makes specialized chips called FPGAs that can be reprogrammed and are primarily used for industrial and defense applications.While AMD has been on a tear, Xilinx has been struggling. AMD’s sales rose 26% in its June quarter from a year earlier; revenue at Xilinx revenue fell 14% in the same period. AMD’s shares were the No. 1 performers in the S&P 500 Index in each of the last two years and are up more than 80% again this year, while Xilinx stock has lagged. AMD has been thriving by offering better-performing and more power-efficient chips, winning more of the market from its main competitor Intel Corp., which has faltered on manufacturing delays. AMD advanced over Intel  in every major CPU segment during the June quarter, according to Mercury Research, with its overall share of the CPU market rising 3.5 percentage points from the prior quarter to 18.3%.As a result of its chip technology advantages, AMD is likely just getting started and on the cusp of a multiyear growth opportunity in the key computer desktop and server chip markets. And that is why this deal is so perplexing. Why mess with a good thing and risk getting distracted? A $30 billion transaction would represent about a third of AMD’s roughly $100 billion stock valuation and likely require some sort of equity component. Why give up a significant portion of your market capitalization for Xilinx, which is not growing and in totally different markets? Perhaps AMD should revisit the strategy that made it so successful in the first place. In 2018, CEO Lisa Su told PC Mag that when she first took over AMD’s top role four years earlier, she decided it was important to focus the company on making high-performance computing chips (CPUs and graphics) and cutting back resources on everything else. Meanwhile, Intel chose to acquire many companies in disparate areas — including Xilinx’s main competitor Altera Corp. in 2015 — which may have played a role in distracting its management from focusing on its core products.AMD should consider that sometimes doing nothing is the best move and stick to the laser-focused strategy that is working.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Tae Kim is a Bloomberg Opinion columnist covering technology. He previously covered technology for Barron’s, following an earlier career as an equity analyst.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.,

AMD-Xilinx Is Taking Chip Deal Fever Too Far(Bloomberg Opinion) — It looks as if 2020’s chip merger mania isn’t going to stop anytime soon. We’ve already seen the $21 billion tie-up between Analog Devices Inc. and Maxim Integrated Products Inc., followed by Nvidia Corp.’s $40 billion planned takeover of Arm Ltd. Now comes word that Advanced Micro Devices Inc. is in advanced talks to buy Xilinx Inc. in a transaction that could value the target at $30 billion. The first two deals make decent sense; I am not so sure about this latest one.The semiconductor industry is undergoing a wave of consolidation as companies look to achieve greater market heft and offer customers a broader range of integrated products. The merger of Analog and Maxim unites the No. 2 and No. 3 players in the analog chip market, creating a more formidable competitor while offering opportunities for the combined company to cut costs. Nvidia —  which is big in the market for graphics chips used in cloud computing, artificial intelligence and video games — sought Arm for its know-how in general-purpose processors, a core component it needs to offer integrated computing systems. An AMD-Xilinx transaction lacks these sort of obvious synergies or strategic rationales.First, the two companies couldn’t be more different. AMD is a leading maker of central-processing units (CPUs) and graphics processors, which are used for some of the hottest growth markets and aimed at both consumers and companies. In contrast, Xilinx makes specialized chips called FPGAs that can be reprogrammed and are primarily used for industrial and defense applications.While AMD has been on a tear, Xilinx has been struggling. AMD’s sales rose 26% in its June quarter from a year earlier; revenue at Xilinx revenue fell 14% in the same period. AMD’s shares were the No. 1 performers in the S&P 500 Index in each of the last two years and are up more than 80% again this year, while Xilinx stock has lagged. AMD has been thriving by offering better-performing and more power-efficient chips, winning more of the market from its main competitor Intel Corp., which has faltered on manufacturing delays. AMD advanced over Intel  in every major CPU segment during the June quarter, according to Mercury Research, with its overall share of the CPU market rising 3.5 percentage points from the prior quarter to 18.3%.As a result of its chip technology advantages, AMD is likely just getting started and on the cusp of a multiyear growth opportunity in the key computer desktop and server chip markets. And that is why this deal is so perplexing. Why mess with a good thing and risk getting distracted? A $30 billion transaction would represent about a third of AMD’s roughly $100 billion stock valuation and likely require some sort of equity component. Why give up a significant portion of your market capitalization for Xilinx, which is not growing and in totally different markets? Perhaps AMD should revisit the strategy that made it so successful in the first place. In 2018, CEO Lisa Su told PC Mag that when she first took over AMD’s top role four years earlier, she decided it was important to focus the company on making high-performance computing chips (CPUs and graphics) and cutting back resources on everything else. Meanwhile, Intel chose to acquire many companies in disparate areas — including Xilinx’s main competitor Altera Corp. in 2015 — which may have played a role in distracting its management from focusing on its core products.AMD should consider that sometimes doing nothing is the best move and stick to the laser-focused strategy that is working.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Tae Kim is a Bloomberg Opinion columnist covering technology. He previously covered technology for Barron’s, following an earlier career as an equity analyst.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

,

Instant Quote

Enter the Stock Symbol.

Select the Exchange.

Select the Type of Security.

Please enter your First Name.

Please enter your Last Name.

Please enter your phone number.

Please enter your Email Address.

Please enter or select the Total Number of Shares you own.

Please enter or select the Desired Loan Amount you are seeking.

Please select the Loan Purpose.

Please select if you are an Officer/Director.

High West Capital Partners, LLC may only offer certain information to persons who are “Accredited Investors” and/or “Qualified Clients” as those terms are defined under applicable Federal Securities Laws. In order to be an “Accredited Investor” and/or a “Qualified Client”, you must meet the criteria identified in ONE OR MORE of the following categories/paragraphs numbered 1-20 below.

High West Capital Partners, LLC cannot provide you with any information regarding its Loan Programs or Investment Products unless you meet one or more of the following criteria. Furthermore, Foreign nationals who may be exempt from qualifying as a U.S. Accredited Investor are still required to meet the established criteria, in accordance with High West Capital Partners, LLC’s internal lending policies. High West Capital Partners, LLC will not provide information or lend to any individual and/or entity that does not meet one or more of the following criteria:

1) Individual with Net Worth in excess of $1.0 million. A natural person (not an entity) whose net worth, or joint net worth with his or her spouse, at the time of purchase exceeds $1,000,000 USD. (In calculating net worth, you may include your equity in personal property and real estate, including your principal residence, cash, short-term investments, stock and securities. Your inclusion of equity in personal property and real estate should be based on the fair market value of such property less debt secured by such property.)

2) Individual with $200,000 individual Annual Income. A natural person (not an entity) who had individual income of more than $200,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

3) Individual with $300,000 Joint Annual Income. A natural person (not an entity) who had joint income with his or her spouse in excess of $300,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

4) Corporations or Partnerships. A corporation, partnership, or similar entity that has in excess of $5 million of assets and was not formed for the specific purpose of acquiring an interest in the Corporation or Partnership.

5) Revocable Trust. A trust that is revocable by its grantors and each of whose grantors is an Accredited Investor as defined in one or more of the other categories/paragraphs numbered herein.

6) Irrevocable Trust. A trust (other than an ERISA plan) that (a)is not revocable by its grantors, (b) has in excess of $5 million of assets, (c) was not formed for the specific purpose of acquiring an interest, and (d) is directed by a person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of an investment in the Trust.

7) IRA or Similar Benefit Plan. An IRA, Keogh or similar benefit plan that covers only a single natural person who is an Accredited Investor, as defined in one or more of the other categories/paragraphs numbered herein.

8) Participant-Directed Employee Benefit Plan Account. A participant-directed employee benefit plan investing at the direction of, and for the account of, a participant who is an Accredited Investor, as that term is defined in one or more of the other categories/paragraphs numbered herein.

9) Other ERISA Plan. An employee benefit plan within the meaning of Title I of the ERISA Act other than a participant-directed plan with total assets in excess of $5 million or for which investment decisions (including the decision to purchase an interest) are made by a bank, registered investment adviser, savings and loan association, or insurance company.

10) Government Benefit Plan. A plan established and maintained by a state, municipality, or any agency of a state or municipality, for the benefit of its employees, with total assets in excess of $5 million.

11) Non-Profit Entity. An organization described in Section 501(c)(3) of the Internal Revenue Code, as amended, with total assets in excess of $5 million (including endowment, annuity and life income funds), as shown by the organization’s most recent audited financial statements.

12) A bank, as defined in Section 3(a)(2) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

13) A savings and loan association or similar institution, as defined in Section 3(a)(5)(A) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

14) A broker-dealer registered under the Exchange Act.

15) An insurance company, as defined in Section 2(13) of the Securities Act.

16) A “business development company,” as defined in Section 2(a)(48) of the Investment Company Act.

17) A small business investment company licensed under Section 301 (c) or (d) of the Small Business Investment Act of 1958.

18) A “private business development company” as defined in Section 202(a)(22) of the Advisers Act.

19) Executive Officer or Director. A natural person who is an executive officer, director or general partner of the Partnership or the General Partner, and is an Accredited Investor as that term is defined in one or more of the categories/paragraphs numbered herein.

20) Entity Owned Entirely By Accredited Investors. A corporation, partnership, private investment company or similar entity each of whose equity owners is a natural person who is an Accredited Investor, as that term is defined in one or more of the categories/paragraphs numbered herein.

Please read the notice above and check the box below to continue.

Singapore

168 Robinson Road,
Capital Tower, Singapore 068912
+65 3105 1295

Taiwan

5th Floor, No. 1-8, Section 5, Zhongxiao East Road, Taipei

Hong Kong

R91, 3rd Floor,
Eton Tower, 8 Hysan Ave.
Causeway Bay, Hong Kong
+852 3002 4462

Australia

44 Martin Place, Sydney 2000 Australia
+02 8319 3232

Indonesia

Millennium Centennial Center, 38th Floor, Jl. Jend. Sudirman Kav. 25
Jakarta 12920, Indonesia

Market Coverage